Share on

Europe Hair Loss Treatment Products Market Segmentation by Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, Others), by End-Use (Homecare Settings, Dermatology Clinics), by Sales Channel (OTC, Prescription), and Country – Forecast to 2027

Published: January, 2022
ID: 10965
Pages: 145
Formats: report pdf report excel report power bi report ppt

Europe Hair Loss Treatment Products Market Forecast 2022 - 2027

The Europe Hair Loss Treatment Products Market is supposed to record a compound annual growth rate (CAGR) of 3.6% during the forecast period of 2022 - 2027.

Hair loss has become a typical concern among people with the increasing pollution levels, work stress, and other medical conditions. In order to combat this issue, several methods were proposed such as the use of hair loss treatment products. These products are clinically tested and approved by dermatologists to be applied on a regular basis. European consumers are among significant contributors to hair loss treatment products.

Market Driving Factors:

One of the major driving factors that help the growth of the Europe Hair Loss Treatment Products Market is the rising disposable income that led to increased purchasing power among local people. Changing fashion trends and a rise in awareness of the availability of new, more effective, and safer hair loss products across the region is also among the driving factors of Europe Hair Loss Treatments Products business.

Increasing concerns among the people regarding hair loss across the area especially among females are one of the major driving factors that help the market to grow further during the forecast period of 2022 - 2027. As per the report, the market of hair loss treatments products in Europe is determined to increase much further owing to an aging population and changing lifestyle of consumers in this area.

Another significant driving factor of Europe Hair Loss Treatment Products Market is the high emphasis on appearances, increasing investments by the major players, and the increasing inclination towards the origin-specific ingredients across the customers in different nations of this area.

Europe Hair Loss Treatment Products Market Restraints:

The high cost of medication is one of the major restraints that is affecting the growth of the market of hair loss treatment products across the European region. Another considerable challenge to the growth of the market of hair loss treatment products is the presence of alternative treatment options such as hair transplant surgery, laser, light-based therapies, etc., which are proven to be effective.

EUROPE HAIR LOSS TREATMENT PRODUCTS MARKET REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2022 - 2027

Base Year

2020

Forecast Period

2022 - 2027

CAGR

3.6% 

Segments Covered

On the basis of disease type, On the basis of distribution channel, On the basis of end-use

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Concert Pharmaceuticals, Hcell Inc, Histogen Inc, Aclaris Therapeutics, Inc, Sun Pharmaceutical Industries Ltd, Merck & Co., Inc, Johnson & Johnson Services, Inc, and Glaxo Smith Kline Plc.

Market Segmentation:

Europe Hair Loss Treatment Products Market On the basis of disease type:

The Europe Hair Loss Treatments Products market is segmented into Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, and Others.

Europe Hair Loss Treatment Products Market On the basis of distribution channel:

The market of Europe Hair Loss Treatment Products Market is bifurcated into over-the-counter (OTC) and prescription-based. Among these, with the surge in online sales, the prescription-based segment is likely to hold the major share of the market in the foreseen years.

Europe Hair Loss Treatment Products Market On the basis of end use:

On the basis of end-use, the Europe Hair Loss Treatment Products Market is segmented into home care settings, dermatology clinics, and others. Among these, the dermatology clinics accounted for the prominent portion, which, however, is supposed to be dominated by homecare settings in the following years.

Regional Analysis:

Based on the region, the European hair loss treatment products market is studied across the nations of Germany, France, Italy, UK, Spain, Norway, etc. Europe is expected to record an increase in the market share of Hair Loss Treatments Products owing to increased hair loss due to changing lifestyles and exposure to the environment, along with the growing popularity of brands in various countries such as Germany. The increasing consumer per capita spending is also estimated to propel the growth of the market of Hair Loss Treatments Products in Europe in terms of revenue rate in the next few years.

Key market players:

Some of the key players operating in the European Hair Loss Treatments Products market are Concert Pharmaceuticals, Hcell Inc, Histogen Inc, Aclaris Therapeutics, Inc, Sun Pharmaceutical Industries Ltd, Merck & Co., Inc, Johnson & Johnson Services, Inc, and Glaxo Smith Kline Plc.

Covid-19 impact on Europe Hair Loss Treatment Products Market:

Coronavirus pandemic has affected the business mainly by directly affecting the production, creating supply chain disturbance and financial burden. This pandemic has impacted financially in every sector like restaurants, manufacturing units, flights, traveling, and so on to halt their services.

Due to the COVID-19, Europe Hair Loss Treatment Products Market is also facing difficulties as several manufacturing industries have stopped production due to the financial crisis they had faced. As per the analysis, experts from the industry are predicting that the market will increase and will be back to the normal stage once the vaccine gets released. The local government has already lifted the lockdown in most of the countries and gave permission for the manufacturing companies to start their businesses with strict rules and regulations.

Please wait. . . . Your request is being processed

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample